We characterized 12 isolates of Streptococcus pneumoniae with various levels of susceptibility to penicillin and extended-spectrum cephalosporins by antimicrobial susceptibility patterns, serotypes, ribotypes, chromosomal DNA restriction patterns by pulsed-field gel electrophoresis, multilocus enzyme electrophoresis patterns, penicillin-binding protein (PBP) profiles, and DNA restriction endonuclease cleavage profiles of pbp1a, pbp2x, and pbp2b. Seven cefotaxime-resistant (MIC, >2 g/ml) serotype 23F isolates were related on the basis of ribotyping, pulsed-field gel electrophoresis, and multilocus enzyme electrophoresis, but they had two slightly different PBP patterns: one unique to strains for which the MIC of penicillin is high (4.0 g/ml) and one unique to strains for which the MIC of penicillin is low (0.12 to 1.0 g/ml). The pbp1a and pbp2x fingerprints were identical for the seven isolates; however, the pbp2b fingerprints were different. An eighth serotype 23F isolate with high-level resistance to cephalosporins was not related to the other seven isolates by typing data but was a variant of the widespread, multiresistant serotype 23F Spanish clone. The PBP profiles and fingerprints of pbp1a, pbp2x, and pbp2b were identical to those of the Spanish clone isolate. An additional serotype 6B isolate with high-level resistance to cephalosporins had unique typing profiles and was unrelated to the serotype 23F cephalosporin-resistant isolates but was related on the basis of genetic typing methods to a second serotype 6B isolate that was cephalosporin susceptible. The serotype 6B isolates had different PBP profiles and fingerprints for pbp1a, but the fingerprints for pbp2x and pbp2b were the same.Penicillin-resistant strains of Streptococcus pneumoniae, first isolated in the late 1960s in Australia, are now prevalent throughout the world and are often associated with resistance to other antimicrobial agents (1, 25). In the United States, previous surveys revealed only sporadic occurrences of penicillin-resistant pneumococcal isolates (prevalence, Յ5% [23,46]); however, more recent surveys show much higher rates of infection caused by resistant pneumococci (14,16,47). Although the optimal therapy for infections caused by penicillinintermediate or -resistant strains of pneumococci has not been established, several reports indicate that cefotaxime or ceftriaxone is the drug of choice for initial empiric therapy for meningitis and sepsis caused by this pathogen (7,14,31).Most pneumococcal isolates that are resistant to penicillin also have increased resistance to extended-spectrum cephalosporins, including cefotaxime and ceftriaxone. The MICs of penicillin are generally equal to or two to four times higher than the MICs of the cephalosporins. Recently, we (45) and others (3, 14, 22) reported on infections caused by pneumococcal isolates that have not responded to cephalosporin therapy and for which the MICs of cefotaxime and ceftriaxone are 2 to 32 g/ml. These MICs are in excess of the MICs of penicillin for these isolat...